OSE Immunotherapeutics S.A.
OSE.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €156,363 | €83,725 | €123,200 | €186,633 |
| - Cash | €16,745 | €18,672 | €25,620 | €33,579 |
| + Debt | €46,132 | €45,802 | €44,793 | €37,133 |
| Enterprise Value | €185,750 | €110,855 | €142,373 | €190,187 |
| Revenue | €69,877 | €2,227 | €18,302 | €26,306 |
| % Growth | 3,037.7% | -87.8% | -30.4% | – |
| Gross Profit | €69,877 | €2,227 | €18,302 | €26,306 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | €41,195 | -€17,501 | -€13,113 | -€13,720 |
| % Margin | 59% | -785.9% | -71.6% | -52.2% |
| Net Income | €37,445 | -€23,003 | -€17,760 | -€16,850 |
| % Margin | 53.6% | -1,032.9% | -97% | -64.1% |
| EPS Diluted | 1.72 | -1.18 | -0.96 | -0.93 |
| % Growth | 245.8% | -22.9% | -3.2% | – |
| Operating Cash Flow | €48,440 | -€19,764 | -€18,252 | -€9,919 |
| Capital Expenditures | -€77 | -€232 | -€274 | -€472 |
| Free Cash Flow | €48,363 | -€19,996 | -€18,526 | -€10,391 |